Padma V. Devarajan

TL;DR: In this paper, a novel pharmaceutical composition comprising polymeric nanoparticles with one or more biologically active agents/s for mucosal and or oral administration is presented. And the compositions are formulated as powders, sprays, suspension, freeze dried powders for reconstitution, tablets, capsules, pellets, wafers, patches, films, rods, pessaries, suppositories, aerosols, bioadhesive gels, creams.

TL;DR: Ionic complexation represents a simple non-covalent approach for anchoring folic acid on polymeric nanoparticles of Gantrez by ionic complexation for folate anchored Rifampicin-Poly methylvinylether maleic anhydride copolymer nanoparticles (RFMGzFa).

TL;DR: Novel biodegradable aliphatic polyesters derived from fatty diacids and fatty diols with even number of carbon atoms, pharmaceutical compositions and applications thereof, wherein the said pharmaceutical compositions comprises at least one pharmaceutically active ingredient and the pharmaceutical compositions is in the form of different drug delivery systems such as drug loaded microparticles, molded implants, coated granules, injectable sustained release particles, stents, films, matrix tablet, coated tablets, dry syrup, mouth dissolving tablets, microparticle dispersed in gels, taste masked formulation, inserts (

TL;DR: It is shown for the first time that the intranasal administration of nanovectorized DHA reduces Tau phosphorylation and restores cognitive functions in two complementary murine models of AD, paving the way for the development of a new approach to target the brain with DHA for the prevention or treatment of this devastating disease.